UNSPSC 51162031: Glycerol, iodinated/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162031 Glycerol, iodinated/theophylline is a Commodity code that does not align with the recent state and local opportunities posted under it. The source shows no solicitations for glycerol, iodinated/theophylline formulations; instead, the tagged opportunities reflect naloxone procurement, on-site pharmacy services, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products. The mismatch suggests either a data classification error in the state and local procurement system or a code reassignment that has drifted from the commodity's original intent. Based on the opportunities actually posted under this code designation, state and local buyers are purchasing finished pharmaceutical products, pharmacy services, and supply-chain management capabilities rather than the specific chemical compounds the code nominally describes.

The recent activity shows issuing bodies from multiple jurisdictions: Seminole County, Florida (naloxone and drug deactivation systems, IFB); Hall County, Georgia (on-site pharmacy services, RFQ); the Texas Health and Human Services Commission (direct-to-manufacturer prescription program exploration, RFI); and the Minnesota Multistate Cooperative Purchasing Alliance (generic multi-source pharmaceuticals and OTC products, RFP). The geographic spread includes Florida, Georgia, Texas, and Minnesota, with cooperative purchasing extending to Oregon. Response dates ranged from April 3, 2026 (Texas RFI) through July 26, 2023 (Seminole County IFB). The only clearly aligned opportunity by typical pharmaceutical commodity standards is the Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, which requires NDC-specific pricing, cGMP and DSCSA compliance, and placement through authorized wholesalers with a July 1, 2026 effective date. Given the code-content mismatch, verify UNSPSC classification with the issuing bodies before pursuing activity under this designation.